Dermatology Online Journal

From WikiMD's WELLNESSPEDIA

Dermatology Online Journal (DOJ) is an open access, peer-reviewed, medical journal that publishes scientific and clinically relevant information on all aspects of cutaneous biology and skin disease. It is the first electronic dermatology journal in the world, established in 1995.

History[edit]

The Dermatology Online Journal was established in 1995 by Arthur C. Huntley, MD, and Bruce E. Onofrey, OD, at the University of California, Davis. The journal was created to provide a platform for the rapid dissemination of high-quality research and clinical observations in the field of dermatology.

Content[edit]

The DOJ publishes original research articles, case reports, reviews, commentaries, and letters to the editor. The journal covers all aspects of skin disease, including clinical dermatology, dermatopathology, dermatosurgery, and basic science research in cutaneous biology.

Open Access[edit]

As an open access journal, all content in the DOJ is freely available without charge to the user or their institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.

Peer Review[edit]

The DOJ operates a rigorous peer review process. All submitted manuscripts are initially assessed by the editor for suitability for the journal. Papers deemed suitable are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper.

Impact[edit]

The Dermatology Online Journal has been instrumental in the advancement of dermatology by providing a platform for the rapid dissemination of high-quality research and clinical observations. It has also played a significant role in promoting open access publishing in the field of dermatology.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.